Respiration, a vital automatic process crucial for life, is finely regulated through a series of complex mechanisms involving various parts of the nervous system and the respiratory tract. Understanding these mechanisms is essential for comprehending how the body responds to different physiological demands and medical conditions. Regulatory Mechanisms in the Medulla The primary control of […]
Hantavirus is a severe and sometimes fatal respiratory disease transmitted to humans through contact with infected rodents, primarily deer mice. The virus belongs to the Bunyaviridae family and presents significant health risks, particularly in rural and natural park areas in the United States. Hantavirus Transmission and Causes of Hantavirus Humans can contract hantavirus through direct […]
Wave Life Sciences and GSK have forged a partnership to discover and develop oligonucleotide therapeutics, focusing on new genetic targets, for respiratory diseases. The discovery collaboration with an initial four-year research term is expected to advance Wave Life Sciences’ preclinical RNA editing program, WVE-006, to treat alpha-1 antitrypsin deficiency (AATD), a disease that impacts the […]
Lupin Limited said that its subsidiary Lupin Healthcare (UK) has secured approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for Luforbec (beclometasone dipropionate/formoterol fumarate dihydrate) 100/6 µg pressurized metered dose inhaler (pMDI). Vinita Gupta – CEO of Lupin Limited said: “We are truly delighted to receive the first marketing authorization for generic Fostair […]
Tenzing Acquisition has agreed to acquire Reviva Pharmaceuticals, a California-based clinical-stage pharma company, focused on developing therapies for addressing unmet medical needs in the areas of central nervous system, metabolic, cardiovascular, and inflammatory diseases. According to the British Virgin Islands-incorporated special purpose acquisition company, the equity value of the combined company post its merger with […]
CF PharmTech, a Chinese pharma company, has raised $50 million in a Series F financing round to accelerate the commercialization of its inhalation products. The investors who took part in the Series F funding round were BioTrack Capital, CICC Qichen, CICC Qide, Watson Investment, SAIC Hengxu, and GP M&A Fund. The existing investors of CF […]
Ruxolitinib coronavirus clinical trial : Incyte revealed that it is working with the US Food and Drug Administration (FDA) to launch the phase 3 RUXCOVID clinical trial to assess the efficacy and safety of ruxolitinib (Jakafi) plus standard-of-care (SoC) in patients with COVID-19 associated cytokine storm syndrome. The ruxolitinib plus standard-of-care will be compared to […]
US biodata company Gatehouse Bio is joining forces with pharma giant AstraZeneca to accelerate the discovery of new drugs for respiratory and cardiovascular diseases using sRNAlytics, the former’s artificial intelligence (AI)-driven platform. According to Gatehouse Bio, the sRNAlytics platform is capable of identifying new small RNA (sRNA) signatures and can illuminate molecular pathways correlated to […]
Roivant Sciences has launched a new biopharma company, Respivant Sciences, to focus on cutting-edge treatments for severe respiratory conditions. The newly established Respivant Sciences will be led by Bill Gerhart as CEO, Ahmet Tutuncu as Executive Vice President for Clinical and Regulatory, and Pravin Soni as Executive Vice President for Development and Manufacturing. This new […]